BioSpace News Archive

PANTHERx® Rare Pharmacy announces that it has been selected by Ultragenyx Pharmaceutical as a limited distribution partner for new drug DOJOLVI™ (triheptanoin).

Cipher Pharmaceuticals Inc. (TSX: CPH) (" Cipher " or " the Company ") is pleased to announce that it has appointed seasoned Financial Executive Scott Langille as its new Chief Financial Officer (CFO), he will succeed Interim CFO Nadine Jutlah . Mr. Langille brings with him an extensive background in corporate and oper

Today, the U.S. Food and Drug Administration further assisted health care providers around the country prepare for the upcoming flu season during the COVID-19 pandemic by issuing an emergency use authorization (EUA) for the third diagnostic test for detection and differentiation of the viruses that cause flu and COVID-19 i

Includes $10,000 Cash Prize + P & G Ventures Partnership Opportunity [02-July-2020] COLUMBIA , Mo. and KANSAS CITY, Mo. , July 2, 2020 /PRNewswire/ -- Healium , the makers of a virtual stress relief product that’s powered by consumer wearables recently won the P & G Ventures Innovation Challenge which includes a $10,000 cash prize, the opportunity to par

Transliquid Technologies LLC is voluntarily recalling all Mystic Shield Protection Topical Solution, manufactured by Mystic Intl S.A. de C.V in Mexico City, and packaged in an 8.45 ounce (250 ml) bottles, to the consumer level.

Citigroup Global Markets Inc., in its capacity as Joint Global Coordinator, notifies that the stabilization period relating to Calliditas Therapeutics AB ‘s American Depositary Shares, traded on The Nasdaq Global Select Market has ended and no further stabilization transactions will be effected.

Milestone Scientific Inc. today announced that on June 30, 2020 it closed its previously announced underwritten offering of 6,520,000 shares of its common stock and warrants to purchase up to an aggregate of 3,260,000 shares of the its common stock. Each share of common stock was sold together with a warrant to purchase 0.5

Continuous, Active Air Purifier Uses NASA-inspired ActivePure Technology

EUSA Pharma announced that the U.S. Food & Drug Administration has approved a randomized, double-blind, placebo-controlled Phase 3 clinical trial protocol to evaluate the safety and efficacy of intravenous siltuximab plus standard of care in hospitalized patients with COVID-19 associated Acute Respiratory Distress Syndrome.

Textile innovator HeiQ’s antiviral textile technology, HeiQ Viroblock NPJ03, has been certified as safe and sustainable as all its ingredients are cosmetic grade, bio-based, and recycled.